InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,277.51
(
0.80%
)
US TECH 100
18,133.20
(
0.58%
)
Dow Jones
38,686.32
(
1.51%
)
Brent Oil
81.01
(
0.25%
)
Bitcoin
69,058.15
(
1.93%
)
Post# of 252012
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 830
Posts 119742
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: randychub post# 12037

Friday, 06/10/2005 10:17:13 AM

Friday, June 10, 2005 10:17:13 AM

Post# of 252012
Re: U.S. ATryn timeline

You don’t have to look at the European trial because the company has given explicit guidance for the U.S. ATryn timeline:

http://library.corporate-ir.net/library/11/114/114239/items/153342/GTCB_2005_Annual_Meeting.pdf
[Slide 16]

Last patient enrolled: mid 2006.
BLA submitted: end 2006.
Approved for U.S. marketing: end 2007.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up